Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis

Biochemical Pharmacology

Volumn 63, Issue 10, 2002, Pages 1831-1842

  Carré, Manon ^a   Carles, Gérard ^a   André, Nicolas ^a   Douillard, Soazig ^a   Ciccolini, Joseph ^b   Briand, Claudette ^a   Braguer, Diane ^a  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Antimicrotubule agents; Apoptosis; Arsenic trioxide; Cytochrome c; Drug combination; Tubulin

Indexed keywords

ARSENIC TRIOXIDE; CYTOCHROME C; DOXORUBICIN; PACLITAXEL; TUBULIN; VINBLASTINE;

ABSORPTION SPECTROPHOTOMETRY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MICROTUBULE; MITOCHONDRION; MITOSIS INHIBITION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; PROTEIN SECRETION; SPECTROFLUOROMETRY; STOICHIOMETRY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CELL DIVISION; DRUG ANTAGONISM; HUMANS; MICROTUBULES; MITOCHONDRIA; OXIDES; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0037094447     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)00922-X     Document Type: Article

References (59)

1. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis
2. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system
3. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
4. Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells
5. Arsenic trioxide and melarsoprol induce programmed cell death in myeloïd leukemia cell lines and function in a PML and PML-RARα independent manner
6. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells
7. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro
8. Induction of mitosis-mediated apoptosis by sodium arsenite in HeLa S3 cells
9. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines
10. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore
11. 4 cell apoptosis with downregulation of BCl-2 expression and modulation of PML-RARα/PML proteins
12. Iodophenylarsine oxide and arsenical affinity chromatography: New probes for dithiol proteins. Application to tubulins and to components of the insulin receptor-glucose transporter signal transduction pathway
13. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis
14. Induction of centrosome injury, multipolar spindles and multipolar division in cultured V79 cells exposed to dimethylarsinic acid: Role for microtubules in centrosome dynamics
15. Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells
16. Inhibition of poly(ADP ribose) polymerase by arsenite
17. Arsenic targets tubulins to induce apoposis in myeloid leukemia cells
18. Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite
19. The taxoids. Comparative clinical pharmacology and therapeutic potential
20. Phase I trial and pharmacological study of a 3-hr paclitaxel infusion in children with refractory solid tumours: A SFOP study
21. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics
22. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: A review
23. Involvement of nuclear factor κB in c-Myc induction by tubulin polymerization inhibitors
24. Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4)
25. Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells
26. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines
27. The effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells
28. Phase II study of paclitaxel and valspodar (psc 833) in refractory ovarian carcinoma: A gynecologic oncology group study
29. New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)
30. Phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction
31. Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies
32. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase
33. Davidson NE. Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines
34. Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
35. Combined arsenic and retinoic acid treatment enhances differenciation and apoptosis in arsenic-resistant NB4 cells
36. Combined effect of all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
37. Arsenic trioxide and ascorbic acid: Synergy with potential implications for the treatment of acute myeloïd leukemia?
38. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukemia: Clinicopathological and molecular features of a pilot study
39. Tau protein is involved in the apoptotic process induced by anti-microtubule agents on neuroblastoma cells
40. Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells
41. Differentiation of human colon cancer cells changes the expression of β-tubulin isotypes and MAPs
42. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
43. Simultaneous combination of microtubule depolymerizing and stabilizing agents acts at low doses
44. The colchicine-binding protein of mammalian brain and its relation to microtubules
45. In vitro effect of Cryptophycin 52 on microtubule assembly and tubulin: Molecular modeling of the mechanism of action of a new antimitotic drug
46. Fluorescent taxoids as probes of the microtubule cytoskeleton
47. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents
48. RPR112378 and RPR115781: Two representatives of a new family of microtubule assembly inhibitors
49. Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells
50. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro
51. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploïd cells by sodium arsenite and vanadium pentoxide
52. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites
53. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437
54. Screening of a library of phage-displayed peptides identifies human Bcl-2 as a taxol binding protein
55. Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2)
56. Heat shock proteins as cellular lifeguards
57. Heat-shock protein 70 antagonizes apoptosis-inducing factor
58. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome